All News Reneo Pharmaceuticals, Inc.

Equities

RPHM

US75974E1038

Real-time Estimate Cboe BZX Other stock markets 01:10:42 16/05/2024 am IST			5-day change	1st Jan Change
1.575 ^USD	-2.78%		-12.02%	+0.63%

13/05	Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise	MT
13/05	OnKure, Inc. entered into an agreement to acquire Reneo Pharmaceuticals, Inc.	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM	07:11am	BU
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Reneo Pharmaceuticals, Inc. - RPHM	14/05	PR
Shareholder Alert: Ademi LLP investigates whether Reneo Pharmaceuticals, Inc. has obtained a Fair Price in its Transaction with OnKure	13/05	PR
RPHM Alert: Monsey Firm of Wohl & Fruchter Investigating Proposed Merger of Reneo Pharmaceuticals With OnKure	13/05	AQ
RPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders	13/05	BU
Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise	13/05	MT
Reneo Pharmaceuticals and OnKure Announce Proposed Merger	13/05	GL
OnKure, Inc. entered into an agreement to acquire Reneo Pharmaceuticals, Inc.	13/05	CI
Reneo Pharmaceuticals, Inc. announced that it expects to receive $65 million in funding from OnKure, Inc., RADIATE MERGER SUB II, LLC, Radiate Merger Sub I, Inc	10/05	CI
Reneo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results	07/05	GL
Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update	28/03	GL
North American Morning Briefing : Tech in Focus on -2-	25/03	DJ
Concentra Biosciences, LLC submitted a non-binding proposal to acquire Reneo Pharmaceuticals, Inc. for $60 million.	26/12	CI
North American Morning Briefing : Stock Futures -2-	18/12	DJ
Reneo Pharmaceuticals, Inc.(NasdaqGM:RPHM) added to NASDAQ Biotechnology Index	18/12	CI
Ladenburg Thalmann Downgrades Reneo Pharmaceuticals to Neutral From Buy	15/12	MT
HC Wainwright Downgrades Reneo Pharmaceuticals to Neutral From Buy, Cuts Price Target to $1.50 From $30	15/12	MT
Sector Update: Health Care Stocks Slipping Late Afternoon	15/12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Reneo Pharmaceuticals, Inc.

Equities

RPHM

US75974E1038

All News

Filters